|By Marketwired .||
|March 19, 2014 08:40 AM EDT|
OTTAWA, ONTARIO -- (Marketwired) -- 03/19/14 -- The Rx&D Health Research Foundation (HRF) is officially accepting nominations for the 2014 Medal of Honour award until April 30th.
The HRF Medal of Honour is granted by the HRF on an annual basis. This award recognizes truly outstanding individuals whose research and/or contribution to public policies supportive of research and development in Canada have achieved international recognition. Since its inception in 1945, this award has been awarded to a number of esteemed individuals, including Sir Alexander Fleming and Dr. Charles Best.
Nominees must be Canadian residents whose work/research has been performed in Canada and has made a truly notable or pivotal contribution to the advancement of knowledge in the health sciences, health policy and/or the improvement of therapeutics and healthcare. Recipients can originate from a variety of fields and sectors including patient groups, educators, journalists, industry, and the public and non-profit sectors.
The $20,000 prize will be invested back into innovative health research at the Canadian academic facility of the recipient's choice to promote further life sciences research in Canada.
More information about the award, including the Nomination Form can be found on the HRF website at www.hrf-frs.com.
About Rx&D Health Research Foundation
Founded in 1964 by Canada's Research-Based Pharmaceutical Companies (Rx&D), the HRF applies the highest standards of scientific excellence to address health challenges of great importance to Canadian society. The Foundation accomplishes its mission through longstanding partnerships with the academic community and government to contribute significantly to the prevention and treatment of disease and to a better healthcare system. The HRF has a proud fifty year history of investing $29 million in funding to more than 1,700 researchers across Canada.
Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada's knowledge-based economy, contributing over $3 billion to the Canadian economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.